Product image of Marcaine Spinal Heavy (Bupivacaine Hydrochloride) supplied by GNH India

Marcaine Spinal Heavy

Active Ingredient:
Bupivacaine Hydrochloride
Origin:
EU

Marcaine Spinal Heavy (Bupivacaine Hydrochloride)

Bupivacaine Hydrochloride, the active ingredient in Marcaine Spinal Heavy, is a local anesthetic presented as a sterile solution for intrathecal use. It provides regional nerve block for surgical, obstetric and postoperative pain management in adult patients.

GNH India supplies Marcaine Spinal Heavy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The product is manufactured under EU standards and distributed to healthcare facilities for use in operating rooms and delivery suites.

Manufacturer / TM Owner

Aspen Pharma Trading Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Marcaine Spinal Heavy, a long‑acting local anesthetic, is used in clinical situations requiring spinal blockade.

  • Spinal anesthesia for surgical procedures: provides dense sensory and motor block for operations requiring regional anesthesia.
  • Obstetric analgesia: delivers effective pain relief during labor while preserving maternal consciousness.
  • Postoperative pain management: extends analgesia after surgery to reduce the need for systemic opioids.

How It Works

  • Bupivacaine Hydrochloride produces reversible blockade of voltage‑gated sodium channels on neuronal membranes, preventing the initiation and propagation of nerve impulses. By inhibiting sodium influx, it halts depolarization of peripheral nerves, resulting in loss of sensation and motor function in the area supplied by the blocked nerves.

Side Effects

Marcaine Spinal Heavy may be associated with a range of adverse reactions, varying from frequent to rare but serious.

Common Side Effects

  • Hypotension: drop in blood pressure due to sympathetic block.
  • Bradycardia: slowed heart rate, especially with high spinal levels.
  • Nausea and vomiting: gastrointestinal upset following block.
  • Pruritus: itching, often after intrathecal administration.
  • Urinary retention: difficulty voiding after the procedure.

Serious or Rare Side Effects

  • Cardiac arrest: severe arrhythmia leading to loss of cardiac output.
  • High spinal block: extensive spread causing respiratory compromise.
  • Seizures: central nervous system toxicity from excessive plasma levels.
  • Severe allergic reactions: anaphylaxis or angioedema.
  • Respiratory depression: inadequate ventilation, particularly when combined with other depressants.

Precautions & Warnings

When using Marcaine Spinal Heavy, clinicians should observe specific safety measures.

  • Patient assessment: evaluate cardiovascular and respiratory status before administration.
  • Dose adjustment: consider reduced doses in elderly or debilitated patients.
  • Contraindications: avoid in patients with known hypersensitivity to bupivacaine or other amide anesthetics.
  • Monitoring: observe blood pressure, heart rate and level of block continuously during the procedure.
  • Drug interactions: review concomitant medications that may potentiate toxicity.
  • Store at controlled room temperature (below 25°C): keep in original packaging, protect from light and moisture.

Avoid Interactions

Marcaine Spinal Heavy can interact with several drug classes; awareness of these interactions helps prevent toxicity.

Major Interactions (Avoid)

  • Other local anesthetics: cumulative toxicity risk.
  • Class I antiarrhythmic agents (e.g., quinidine): may precipitate severe cardiac arrhythmias.
  • Beta‑blockers: can enhance bradycardia and hypotension.

Moderate Interactions (Monitor Closely)

  • Epinephrine: may prolong block duration and increase systemic absorption.
  • Central nervous system depressants (e.g., opioids, benzodiazepines): additive sedation and respiratory depression.

Frequently Asked Questions

Marcaine Spinal Heavy is employed to produce a spinal (intrathecal) block for surgical anesthesia, to provide analgesia during labor and delivery, and to extend pain relief after surgery, reducing the need for systemic opioid medications.

Bupivacaine blocks voltage‑gated sodium channels on nerve membranes, preventing the influx of sodium ions required for depolarisation. This inhibition stops the propagation of nerve impulses, resulting in loss of sensation and motor function in the targeted region.

The dose of Marcaine Spinal Heavy is determined by the prescribing clinician based on the type of procedure, patient characteristics and desired block level. Specific dosing regimens are not disclosed publicly and should follow the prescriber’s instructions.

Safety data for intrathecal bupivacaine in pregnancy and lactation are limited. Use is generally reserved for obstetric procedures when the benefits outweigh potential risks, and the decision should be made by the treating obstetrician in consultation with the patient.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Compared with shorter‑acting agents such as lidocaine, bupivacaine provides a longer duration of sensory and motor block, which can be advantageous for prolonged surgeries or postoperative analgesia. However, its higher potency also requires careful dosing to avoid systemic toxicity.

The product should be stored at controlled room temperature, below 25 °C, in its original sealed container. Protect it from direct light and moisture, and avoid freezing. Handling should be performed using aseptic technique to maintain sterility.

Marcaine Spinal Heavy is administered by a qualified healthcare professional via a single intrathecal injection into the cerebrospinal fluid of the lumbar subarachnoid space, using a sterile spinal needle under aseptic conditions.

Serious risks include cardiac arrest, severe arrhythmias, high spinal block leading to respiratory compromise, central nervous system toxicity such as seizures, and allergic reactions. Immediate monitoring and emergency preparedness are essential during and after administration.

Patients with known hypersensitivity to bupivacaine or other amide‑type local anesthetics, those with severe cardiac conduction disorders, uncontrolled hypotension, or certain neuromuscular diseases should avoid this product unless a risk‑benefit assessment justifies its use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.